Related Experiment Videos
Renal carcinoma: a ten-year review 1971-1980
1Department of Surgery, Royal Victoria Hospital, Belfast.
British Journal of Urology
|August 1, 1987
Summary
This study reviewed 72 renal carcinoma patients undergoing nephrectomy. Advanced stage 4 cancer significantly reduced survival, while malaise indicated a poor prognosis for kidney cancer patients.
Area of Science:
- Urology
- Oncology
- Nephrology
Background:
- Renal carcinoma, a significant cause of cancer-related mortality, necessitates effective treatment strategies.
- Nephrectomy remains a primary surgical intervention for renal tumors.
Purpose of the Study:
- To analyze the survival rates of patients with renal carcinoma after nephrectomy.
- To identify clinical, operative, and pathological factors influencing patient outcomes.
Main Methods:
- Retrospective review of 72 patients diagnosed with renal carcinoma between 1971 and 1980.
- Nephrectomy as the surgical treatment for all patients.
- Minimum 5-year follow-up for all survivors.
Main Results:
- A 65% 5-year survival rate was observed for patients with stage 1 to 3 renal carcinoma.
- All patients diagnosed with stage 4 disease succumbed to the cancer within 2 years.
- The presence of malaise was a highly significant adverse prognostic factor (P = 0.0014).
Conclusions:
- Tumor stage is a critical determinant of survival in renal carcinoma patients post-nephrectomy.
- Early-stage renal carcinoma offers a favorable prognosis.
- Malaise is a significant indicator of poor outcomes in renal carcinoma.